The estimated Net Worth of Matthew D Dallas is at least 61.4 千$ dollars as of 16 January 2015. Matthew Dallas owns over 3,075 units of Biostage stock worth over 58,459$ and over the last 10 years Matthew sold BSTG stock worth over 2,937$.
Matthew has made over 2 trades of the Biostage stock since 2015, according to the Form 4 filled with the SEC. Most recently Matthew sold 3,075 units of BSTG stock worth 2,522$ on 16 January 2015.
The largest trade Matthew's ever made was selling 3,075 units of Biostage stock on 16 January 2015 worth over 2,522$. On average, Matthew trades about 513 units every 1 days since 2015. As of 16 January 2015 Matthew still owns at least 14,506 units of Biostage stock.
You can see the complete history of Matthew Dallas stock trades at the bottom of the page.
Matthew's mailing address filed with the SEC is C/O AVEO PHARMACEUTICALS, INC., 650 E. KENDALL STREET, CAMBRIDGE, MA, 02142.
Over the last 8 years, insiders at Biostage have traded over 962,849$ worth of Biostage stock and bought 1,593,581 units worth 3,804,230$ . The most active insiders traders include David Green、Capital Llc Dst、Ronald J Packard. On average, Biostage executives and independent directors trade stock every 79 days with the average trade being worth of 217,604$. The most recent stock trade was executed by Capital Llc Dst on 6 April 2023, trading 62,500 units of BSTG stock currently worth 375,000$.
Biostage, Inc., a biotechnology company, engages in developing bioengineered organ implants based on its Cellframe technology. The company's Cellframe technology comprises a biocompatible scaffold that is seeded with the recipient's own stem cells. It is developing its Cellframe technology to treat life-threatening conditions of the esophagus, bronchus, or trachea. The company was formerly known as Harvard Apparatus Regenerative Technology, Inc. and changed its name to Biostage, Inc. in March 2016. Biostage, Inc. was founded in 2007 and is headquartered in Holliston, Massachusetts.
Biostage executives and other stock owners filed with the SEC include: